Procept BioRobotics Corp. is a healthcare company based in the United States that specializes in surgical robotics. They are dedicated to enhancing patient care by creating innovative solutions in urology. The company's ESG score is 28.6, categorizing it as a medium-risk investment. Procept BioRobotics Corp. develops, manufactures, and sells the AquaBeam Robotic System, a cutting-edge surgical robotics system used in minimally invasive urologic procedures, particularly for treating benign prostatic hyperplasia (BPH). Their revenue primarily comes from sales of the AquaBeam Robotic System and its disposable handpieces.